Here is an excerpt from my Q&A with Joe and Rich during the

New Post Public Reply Private Reply Replies (0) Message Board
tc2000chartreader
389
Here is an excerpt from my Q&A with Joe and Rich during the 10/15/19 conf call. They never really did answer the question about how long it takes to manufacture excellagen, nor the cost, so it must have been from a prior conf call.

https://storage.googleapis.com/wzukusers/user...152019.pdf

Steve: Okay. I saw the wound closures with Excellegen, and I mean that's awesome,
the wound closure pictures--I mean the pictures tell a thousand words, so that
looks like an excellent process. And how are we coming along on
manufacturing that product? Is there... what of time lag is it to grow that
product or develop it to be able to be resold to help people?
Joe: There's always a time lag for manufacturing. But right now, we're still in the
launch, right? So, let's put it like this--Rich Purcell could probably add to
this... but you have to give out a lot, a lot of products, as far as samples, to
doctors, institutions, to wound clinics, to hospitals, for them to go through
their process of testing the product on patients before they actually start
ordering and you start making money.
Steve: Good point.
Joe: So, we've gone through a lot of that already, and now everything has just
really picked up and so have the costs of that. So, Rich, maybe you can add a
little to that on the process.
Richard: Sure. Happy to, Joe. The first batch of products was made in the 0.8cc
syringe, and they were distributed to hospitals and the VA, where the valueadd committees--the VAT committees--evaluating the products to see if it'll
go into surgical units, and this is where in the hospital, these units are using
Excellegen for surgeries and for diabetics, put in all sorts of venous leg
ulcers, for various treatments with 17 different wounds that Excellegen can
be used for as cleared by the FDA.
So, there's a whole process that goes on in using this in a surgical suite under
a DRG. And that's what's going on. We just launched a 3cc syringe, and now
there's 0.5, 0.8, and 3 cc syringes, and they're all available, and they're being
sold now, and there's an uptake in the market apparently right now. It's being
distributed through McKesson, and we just signed another agreement with a
distributor specializing in the VA, and they're under a federal supply contract,
so they're an FFF supplier, and that should open up the VA to further
distribution going forward.
So, we're really excited about the use of it; we've got very good feedback
from the market. To date, we've got some great anecdotal evidence, and the
SAWC just ended up where the whole team from all the regions has been out,
and actually _____ [00:53:44] would be on the call right now, otherwise, he'd
be on the plane coming back from SAWC.
But _____ [00:54:07] presented Excellegen data--the SAWC is the wound
convention that was just held in Las Vegas. And there's a manuscript that's
GENEREX_10152019
Page 16 of 28
just published as well. So, we're really excited about the efficacy... obviously,
the safety is clear--it's a Collagen product, there are no safety issues
whatsoever, and the efficacy is wonderful. We're getting great feedback from
the physicians who are getting use out of it in the VAT Committee reviews,
and we have private practitioners who can use the gel in the office to treat
diabetic foot ulcers in office instead of sending everybody to a wound clinic
every time.
So, I think there's a whole lot of--
Steve: That brings up a few questions. The three questions would be--again, not
being a scientist, you said 0.5, 0.8, and 3cc syringes. So, the first question
would be like what size of wounds does that treat? The second question then
would be, are you able to share a cost structure as far as what it's being sold
for? But I guess you probably don't want to do that for a couple competitions.
Richard: There's a couple of things here. There is a very easy answer on the coverage:
the reason that it's sold in three different sizes, is to eliminate waste. One of
the problems with the current cellular and tissue therapy products is that they
come in sheets--they're tissue sheets; they have to be cut to the size of the
wound, and you throw the rest away. So, these are thousands of dollars they
cost.
Steve: Yeah, it's a frozen product versus our refrigerated product.
Richard: Right, and our products last for two months in the refrigerator--their products
have to be thrown away after seven days. But it's not even about the
competitors here, it's more about us and keeping the price of a cellular tissue
therapy specific to what that patient needs. So, if you have a 30 square
centimeter wound, that's a 3 cc syringe; an 8 square centimeter wound is a 0.8
cc. So, the square centimeter is defined by the size, and you can make mix
match--it's all priced under linear pricing too, and you can get that pricing
from the _____ [00:56:45] physician.
Joe: I'll give you one example of how. So, we sent the product to one hospital--
they wanted samples--and one of the doctors had a patient that was scheduled
for amputation. The wounds were hugely...
Richard: They venous leg ulcers and wounds that were open and wouldn't heal.
Joe: Yeah, and they wouldn't heal. And so, the doctor said, "Before I go in for an
amputation, let's try this product out on him." He applied the product
multiple, multiple times, now the patient kept his leg complete from the knee
down, is walking around on it, it's vascular again, and all the wounds are
closed up. So, the product has been far exceeding our expectations on even
more tragic wounds it is working on.
GENEREX_10152019
Page 17 of 28
Steve: That's awesome. I mean I guess Rich answered my question. I was curious as
to a 3 cc size, and he mentioned it's 30 cm...
Richard: 30 square centimeters of 3 cc.
Steve: Okay, so that gives an idea of how much. Now, one last question for you,
Rich, then, let's say we're totally out, how long does it take to manufacture--
Richard: Who's out? Who's out of what?
Steve: Well, I'm saying let's say you're totally out of product. [Laughter]
[Crosstalking]
Richard: No, there's no question of being out. If we run out, everybody is going to be
very happy. If we run out of all the products we've made, everybody would
be very happy.
Steve: Sure. Well, as I said, I'm just trying to figure out, to make a 3 cc, it takes us a
month--
Richard: Yeah, it's like market research. No, everything is on target for our
manufacturing.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 125

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
GAC Dominates with 8 Awards in Cutting-Edge Tech

Updated Category News Views 238

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Continue Reading
Naviu's AI Travel Guide: Revolutionizing Japan Tours

Updated Category News Views 134

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 215

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Updated Category News Views 124

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Continue Reading
Voting for Future Urban Icons Begins Globally

Updated Category News Views 160

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

Continue Reading
Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 131

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 213

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 113

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
XPeng Hits New Monthly Delivery Record in October

Updated Category News Views 148

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

Continue Reading

Top 5 Most Recently Viewed Articles

CEO Marvin McLellan Charts New Course for Excelsior

Updated Category News Views 128

A New Era Begins for Excelsior Ambulance Ever get that feeling when a company just seems poised on the brink, ready to leap into its next chapter? That's the vibe down at Excelsior Ambulance. They've got a seasoned hand at the helm now with Marvin McLellan stepping in as the new Chief Executive Officer. And from the looks of it, they’re prepping for quite the...

Continue Reading
Ripple CTO Discusses XRP and Bitcoin's Circulating Supply Insights

Updated Category News Views 589

Understanding Circulating Supply in Crypto In a recent conversation, Ripple CTO David Schwartz shed light on the complexities surrounding the circulating supply of XRP, drawing interesting parallels to Bitcoin. His insights delve into the intricacies of how circulating supply is defined within the ever-evolving cryptocurrency landscape. XRP's Circulating Supply...

Continue Reading
UK Economic Challenges: Insights on Recent GDP Contraction

Updated Category News Views 277

The UK's Economic Contraction: A Cautionary Sign The UK economy faced a surprising setback recently, with a second consecutive month of contraction that has raised alarm among policymakers. Following a reported 0.1% decline in GDP in May, which came after an even steeper 0.3% drop in April, the unexpected figures defy the expectations of economists who anticipated a...

Continue Reading
Exploring Cultural Nuances in Generative AI Responses

Updated Category News Views 252

Generative AI and Cultural Influence The ever-evolving field of generative AI raises intriguing questions about its responses across different languages. Researchers have been examining how cultural nuances can shape the answers provided by algorithms. A significant study conducted by experts has highlighted that generative AI does indeed reflect cultural patterns,...

Continue Reading
Mobile Iron IV Expansions: Targeting Texas Health Needs

Updated Category News Views 38

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Continue Reading